$9.80
0.444.70%
At close: -
$9.80
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Stoke Therapeutics (NASDAQ:STOK) Stock, Earnings Estimates, EPS, And Revenue
Stoke Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 24
EPS Estimate
$-0.560
Quarterly Revenue Estimate
$2.97M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$16.74M
Analyze the earnings history of Stoke Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Stoke Therapeutics (STOK) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-05 | $-0.47 | $-0.53 | 11.3 % |
| Q2 | 2024-08-07 | $-0.46 | $-0.55 | 16.4 % |
| Q1 | 2024-05-06 | $-0.57 | $-0.61 | 6.56 % |
| Q4 | 2024-03-25 | $-0.60 | $-0.63 | 4.76 % |
Stoke Therapeutics (STOK) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-05 | $4.89M | $3.35M | 46.1 % |
| Q2 | 2024-08-07 | $4.83M | $3.41M | 41.7 % |
| Q1 | 2024-05-06 | $4.22M | $3.21M | 31.3 % |
| Q4 | 2024-03-25 | $2.80M | $3.25M | -13.8 % |
FAQ
When is Stoke Therapeutics (NASDAQ:STOK) reporting earnings?
Stoke Therapeutics (STOK) is scheduled to report earnings on March 24, 2025. The last reported earnings were for reported on November 5, 2024 for Q3.
What were the latest earnings per share (EPS) for Stoke Therapeutics (NASDAQ:STOK)?
The Actual EPS was $-0.47, which beat the estimate of $-0.53.
What were Stoke Therapeutics’s (NASDAQ:STOK) revenues?
The Actual Revenue was $4.9M, which beat the estimate of $3.4M.
Browse earnings estimates, EPS, and revenue on all stocks.